Citius Oncology, Inc.

192 articles about Citius Oncology, Inc.

• Citius Pharma To Present At The Rodman & Renshaw 18th Annual Global Investment Conference

  9/7/2016

• Citius Pharma Announces Completion Of In-Depth Interviews On Patient-Reported Outcomes: Signs And Symptoms Of Hemorrhoids And Treatments

  8/23/2016

• Citius Pharma Provides Shareholder Update On Recent Achievements

  8/1/2016

• Citius Pharma Addresses Problem That Affects 10 Million People In The U.S.: Hemorrhoids

  7/25/2016

• Citius Pharma Completes Feasibility Study Of Investigator Sites For Mino-Lok Phase 3 Trials

  7/18/2016

• Citius Pharma Discontinues Development of Weight Loss Drug Suprenza

  7/5/2016

• Citius Pharma Announces Appointment Of Dr. Eugene Holuka To Its Board Of Directors

  6/28/2016

• Citius Pharma Announces Completion Of Private Placement Financing

  5/12/2016

• Citius Pharma Completes Acquisition Of Leonard-Meron Biosciences

  4/4/2016

• Citius Pharma Announces Significant Equity Investment From Chairman And CEO

  3/23/2016

• Citius Pharma Signs Letter Of Intent To Acquire Leonard Meron Biosciences

  3/7/2016

• Citius Pharma Announces Results From Phase 2a Trial Of Hydrocortisone And Lidocaine Combination Cream In Patients With Grade I And II Hemorrhoids

  2/1/2016